Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) Profit After Tax (2016 - 2025)

Historic Profit After Tax for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$18.1 million.

  • Medifast's Profit After Tax fell 236204.74% to -$18.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$18.7 million, marking a year-over-year decrease of 99254.3%. This contributed to the annual value of -$18.7 million for FY2025, which is 99296.99% down from last year.
  • According to the latest figures from Q4 2025, Medifast's Profit After Tax is -$18.1 million, which was down 236204.74% from -$2.3 million recorded in Q3 2025.
  • Medifast's Profit After Tax's 5-year high stood at $47.0 million during Q2 2021, with a 5-year trough of -$18.1 million in Q4 2025.
  • Over the past 5 years, Medifast's median Profit After Tax value was $24.8 million (recorded in 2022), while the average stood at $19.5 million.
  • Examining YoY changes over the last 5 years, Medifast's Profit After Tax showed a top increase of 13041.45% in 2025 and a maximum decrease of 236204.74% in 2025.
  • Medifast's Profit After Tax (Quarter) stood at $34.0 million in 2021, then fell by 22.06% to $26.5 million in 2022, then crashed by 77.24% to $6.0 million in 2023, then plummeted by 86.73% to $801000.0 in 2024, then tumbled by 2362.05% to -$18.1 million in 2025.
  • Its Profit After Tax stands at -$18.1 million for Q4 2025, versus -$2.3 million for Q3 2025 and $2.5 million for Q2 2025.